Navigation Links
New targeted drug helps smokers stub it out
Date:3/17/2011

Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.

Nicotine is absorbed rapidly through the lining of the mouth but most readily through the lungs, from where it quickly passes through the body and into the brain. Once the nicotine reaches the liver, it is metabolised by an enzyme called CYP2A6. Preliminary studies by the Canadian partner of the research project have shown that inhibitors of the nicotine-metabolising CYP2A6 enzyme can help smokers curb the need to smoke. Unfortunately, current CYP2A6 inhibitors are not viable options for anti-smoking therapy, as they involve too many adverse effects.

"We're working on developing a CYP2A6 inhibitor, a targeted drug that would only be effective in specific parts of the body. Thankfully, we have a very clear picture of the structure of CYP2A6, and we'll be able to use computer-aided modelling methods to design molecules that will bind specifically to the target without disturbing other functions in the body. We've now finished our four-year project and have discovered several molecules of an until-now-unknown structure. Along the way, we've gained new insights into how the molecules bind to the active centre of the CYP2A6 enzyme. However, it'll take a good while and money before these molecules can be developed into a targeted drug," says Hannu Raunio, the principal investigator of the research project and Professor of Pharmacology at the University of Eastern Finland.

Traditional anti-smoking therapy has long been focused on smoking cessation. At present, there are a wide variety of treatments available to help smokers quit. Nicotine, buproprion and varenicline are among the most common drugs used in the treatment of smoking addiction. The idea behind pharmaceutical nicotine products is to relieve and prevent withdrawal symptoms so as to pave the way for smoking cessation. However, such forms of treatment are often unsuccessful, which has led to suggestions that new methods are needed, methods that would help in smoking reduction. It is this type of targeted drug that Raunio's project is developing.


'/>"/>

Contact: Professor Hannu Raunio
hannu.raunio@uef.fi
358-405-200-202
Academy of Finland
Source:Eurekalert

Related medicine news :

1. Ohio State study: Targeted ovarian cancer therapy not cost-effective
2. VCU Massey first to combine targeted agents to kill multiple myeloma cells
3. IU Personalized Medicine Institute to develop targeted and individualized treatments
4. Targeted particle fools brains guardian to reach tumors
5. PET scans may allow early prediction of response to targeted therapy of thyroid cancer
6. UMMS and Lundbeck to explore potential targeted therapy for Huntingtons disease
7. Study provides molecular rationale for combining targeted agents to treat breast cancer
8. Protein targeted to stop melanoma tumor growth
9. International clinical trial tests targeted drug for melanoma
10. Targeted breast ultrasound plays key role in evaluating breast abnormalities in women younger than 40
11. Targeted therapy reactivates guardian of the genome in resistant cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... The University of Tennessee Medical Center ... the latest in Clinical Patient Pod (CPP) technologies provided through Jvion’s ... into the clinical workflow. These insights are empowering the more than 30 case ...
(Date:5/31/2016)... Calif. (PRWEB) , ... May 31, 2016 , ... Effective ... colleagues, clients, and the industry as a whole. On June 2, Northbound CEO Mike ... on Addictive Disorders (WCSAD) and presenting the opening plenary on “Leadership: The Journey to ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... ... planetary and numeral energies can describe personality traits in humans. Using presidential candidate ... behind their name and vitality. , “AstroNumerology is not about adding numbers ...
(Date:5/31/2016)... ... ... TeaZa® Energy, LLC announces the launch of a new limited ... . The new flavor—Tropical TeaZa? Energy—will be available to customers exclusively online starting ... flavor is best described as a juicy, taste bud takeover. A mouthwatering wave ...
(Date:5/31/2016)... ... May 31, 2016 , ... To ... solutions to the healthcare industry, The University of Scranton is adding a Certificate ... path to a career in rapidly growing field of healthcare information. , ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 31, 2016 Aloe vera extracts ... cosmetics and pharmaceuticals, with global volume to surpass 60,720.4 ... Bn. Demand for aloe vera extracts for ... will continue its upward momentum in 2016 as well. ... positive sentiment on aloe vera, with wide-ranging applications in ...
(Date:5/31/2016)... 31, 2016 The global biomaterials market ... surging prevalence of deaths from chronic diseases. According to research ... By Country): Opportunities and Forecasts (2016-2021) - (By Value; By ... Plastic Surgery, Wound Care); By Region-North America, Europe ... Germany , Italy , ...
(Date:5/31/2016)... , May 31, 2016 , Isansys ... for its Patient Status Engine wireless patient monitoring platform, as ... , Germany , Scotland ... company,s 2 nd generation system, launched earlier this year, is ... world , , This new technology significantly ...
Breaking Medicine Technology: